Together, We Will Protect America’s Medicine Cabinet and Solve Our Nation’s Drug Shortage Crisis Richmond, Virginia, September 8, 2023 – Phlow announced today that it will honor the 3rd National Essential Medicine Shortage Awareness Day (NEMSAD), a national observance...
Corporate Statements
Phlow and OrbitalRX Improve Pharmaceutical Supply Chain Management within Hospital Pharmacies Through Strategic Partnership
Phlow, a public benefit corporation on a mission to ensure a reliable supply of medicines essential for pediatric care, is proud to partner with OrbitalRX and its one-of-a-kind drug shortage management platform. OrbitalRX is designed by pharmacists, for pharmacists to...
Phlow Recognizes National Essential Medicine Shortage Awareness Day
Solving America’s drug shortage crisis continues to be a complex challenge that will take the effort, collaboration, and innovation of many to solve Richmond, Virginia, September 8, 2022 – Phlow announced today that it will be observing National Essential Medicine...
Phlow Corp.’s Statement on Essential Medicines Supply Chain and Manufacturing Resilience Assessment
Phlow Corp. is pleased to see the release of the Essential Medicines Supply Chain and Manufacturing Resilience Assessment, an action plan developed by the National Forum to Secure America’s Supply Chain for Essential Medicines. Phlow, a U.S.-based essential medicines...
Statement of Phlow Corp. on the Introduction of the “PREPARE Act”
Phlow Corp. released the following statement on the introduction of S.2740, the Promoting Readiness and Ensuring Proper Active Pharmaceutical Ingredient Reserves of Essential Medicines (PREPARE) Act of 2021 in the United States Senate.